Key result
Systolic trans-bridge pressure gradient linked to ~16% higher odds of angina per 1% increase.
Why the study?
The relationship between myocardial bridging morphology and function and the pathways to clinical symptoms remained unclear.
Does the delta coronary computed tomographic angiography-derived fractional flow reserve (ΔCT-FFR) and myocardial bridge morphology predict and mediate angina-equivalent clinical symptoms in patients with deep left anterior descending myocardial bridging without coronary atherosclerosis?
Cohort (n=180)
No
Does the delta coronary computed tomographic angiography-derived fractional flow reserve (ΔCT-FFR) and myocardial bridge morphology predict and mediate angina-equivalent clinical symptoms in patients with deep left anterior descending myocardial bridging without coronary atherosclerosis?
Myocardial bridge depth and systolic trans-bridge CT-FFR pressure gradient independently predict angina-equivalent symptoms, with the systolic gradient significantly mediating the relationship between bridge depth and clinical presentation.
Answers are grounded in this paper and cite their sources.
ΔCT-FFRsys and bridge depth were associated with angina in myocardial bridging; hypothesis-generating for CT-based assessment and requires prospective validation before clinical use.
Objective The relationship between myocardial bridging (MB) morphology and function and the pathways to clinical symptoms remained unclear. This study investigated the association between delta coronary computed tomographic angiography-derived fractional flow reserve (ΔCT-FFR) and angina-equivalent symptoms in left anterior descending MB without coronary atherosclerosis using photon-counting detector CT (PCD-CT). Materials and methods This retrospective cohort included 180 patients with deep MB (depth > 2 mm) and no plaques. All underwent PCD-CT angiography. CT-FFR was computed by machine learning; systolic (ΔCT-FFRsys) and diastolic (ΔCT-FFRdia) trans-bridge pressure gradients were derived. MB depth and length were measured. Associations with symptoms were assessed by logistic regression and mediation analysis. Results Symptomatic patients ( n = 81) had greater depth (median 3.30 mm vs. 2.45 mm), longer length (mean 36.06 mm vs. 26.10 mm), higher ΔCT-FFRsys (3.81% vs. 1.62%) and ΔCT-FFRdia (3.45% vs. 2.15%) than asymptomatic patients ( n = 99) (all p < 0.001). Multivariable analysis identified depth (OR = 1.77, 95% CI: 1.27–2.46, p = 0.001) and ΔCT-FFRsys (OR = 1.16, 95% CI: 1.05–1.27, p = 0.002) as independent predictors. Mediation analysis indicated that ΔCT-FFRsys significantly mediated the effect of depth on symptoms (indirect effect = 0.1881, 95% CI: 0.1023–0.2897). Conclusions MB depth and ΔCT-FFRsys were independent risk factors for symptoms, and ΔCT-FFRsys appeared to mediate the morphological-clinical symptoms link. These findings suggested that integrated assessment, particularly ΔCT-FFRsys, might be a new non-invasive imaging biomarker for clinically identify symptomatic MB and understand its potential pathogenic mechanisms. Key Points Question The precise relationship between myocardial bridging morphological and functional features and clinical symptoms, and whether underlying key mediating factors exist, remains currently incompletely determined. Findings Depth, length, and systolic trans-bridge pressure gradient of myocardial bridging independently predicted symptoms, with the gradient significantly mediating the relationship between morphology and clinical presentation . Clinical relevance Noninvasive assessment of depth and systolic trans-bridge pressure gradient can assist in identifying patients with symptomatic myocardial bridging, serving as potential imaging biomarkers and providing insights into the underlying pathophysiology of symptom presentation .
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) conducted a cohort in Deep left anterior descending myocardial bridging without coronary atherosclerosis (n=180). Systolic trans-bridge pressure gradient (ΔCT-FFRsys) and myocardial bridge depth vs. Asymptomatic patients with deep myocardial bridging (n = 99) was evaluated on Presence of angina or angina-equivalent clinical symptoms (per 1% increase in ΔCT-FFRsys) (OR 1.16, 95% CI 1.05–1.27, p=0.002). Systolic trans-bridge pressure gradient (OR 1.16, 95% CI 1.05–1.27, p=0.002) and bridge depth (OR 1.77, p=0.001) independently predicted angina symptoms in deep LAD myocardial bridging.
Synapse has enriched 10 related papers. Consider them for comparative context: